D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CRL holding history
Charles River Laboratories International, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRL overviewAll 13F holders of CRLFull Q2 2026 holdings
- Shares (Q2 2026)
- 31,587
- Value
- $7.16M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 31,587 | $7.16M | <0.1% | −161,896−83.7% | Reduced | Holders |
| Q1 2026 | 193,483 | $33.4M | <0.1% | −237,645−55.1% | Reduced | Holders |
| Q4 2025 | 431,128 | $86.0M | 0.1% | −528,409−55.1% | Reduced | Holders |
| Q3 2025 | 959,537 | $150.1M | 0.1% | +352,518+58.1% | Added | Holders |
| Q2 2025 | 607,019 | $92.1M | 0.1% | +607,019 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −84,656−100.0% | Sold out | Holders |
| Q4 2024 | 84,656 | $15.6M | <0.1% | +84,656 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −4,857−100.0% | Sold out | Holders |
| Q4 2023 | 4,857 | $1.15M | <0.1% | +3,737+333.7% | Added | Holders |
| Q3 2023 | 1,120 | $219.5K | <0.1% | +1,120 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −12,022−100.0% | Sold out | Holders |
| Q1 2023 | 12,022 | $2.43M | <0.1% | −22,687−65.4% | Reduced | Holders |
| Q4 2022 | 34,709 | $7.56M | <0.1% | −66,323−65.6% | Reduced | Holders |
| Q3 2022 | 101,032 | $19.9M | <0.1% | −66,438−39.7% | Reduced | Holders |
| Q2 2022 | 167,470 | $35.8M | 0.1% | +59,310+54.8% | Added | Holders |
| Q1 2022 | 108,160 | $30.7M | <0.1% | +107,148+10,587.7% | Added | Holders |
| Q4 2021 | 1,012 | $381.0K | <0.1% | −1,815−64.2% | Reduced | Holders |
| Q3 2021 | 2,827 | $1.17M | <0.1% | +1,985+235.7% | Added | Holders |
| Q2 2021 | 842 | $311.0K | <0.1% | +842 | New | Holders |